Page last updated: 2024-10-31

modafinil and Amyotonia Congenita

modafinil has been researched along with Amyotonia Congenita in 1 studies

Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.

Research Excerpts

ExcerptRelevanceReference
"Fatigue is a common and potentially debilitating symptom of neuromuscular disease (NMD)."2.46Assessment and management of fatigue in neuromuscular disease. ( Carter, GT; Lou, JS; Weiss, MD, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lou, JS1
Weiss, MD1
Carter, GT1

Reviews

1 review available for modafinil and Amyotonia Congenita

ArticleYear
Assessment and management of fatigue in neuromuscular disease.
    The American journal of hospice & palliative care, 2010, Volume: 27, Issue:2

    Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Exercise; Fatigue; Humans; Modafinil; Muscl

2010